Twitter | Search | |
PRECIS-2
PRECIS-2 tool: to design trials that are fit for purpose. Helping trialists consider the impact design decisions have on applicability of results
201
Tweets
146
Following
243
Followers
Tweets
PRECIS-2 retweeted
PCT Grand Rounds Jun 1
Did you know? About 20% of the major clinical decisions are based on
Reply Retweet Like
PRECIS-2 retweeted
Dr Elaine Toomey May 25
Ken Freedland and team - how to decide on appropriate comparators within trials at
Reply Retweet Like
PRECIS-2 retweeted
Linda Bauld May 25
implemented legislation this week to legalise products. The key point here is that Canada has drawn a clear line between these products + tobacco. The info section for smokers in particular draws on evidence from
Reply Retweet Like
PRECIS-2 retweeted
Charles Weijer May 25
Congratulations to of team members et al who were leading at in Portland. SCT participants sent 1.6K generating 1.8M tweet . WOW!
Reply Retweet Like
PRECIS-2 May 23
Wynne Norton describing the PRECIS-MultiLevel tool to help trialists design cluster trials randomising at the provider level with at the patient level.
Reply Retweet Like
PRECIS-2 retweeted
BMC Medical Evidence May 22
In the innovative trial designs session at ? Here is a link to the paper in that has been referencing in his SWAT talk: A definite must-read for anyone interested in doing a SWAT!
Reply Retweet Like
PRECIS-2 retweeted
Kirsty Loudon May 23
got the button to work to tell us about the uk funders work & how they answer real world questions using original question wheel and after panel meeting wheel changed!
Reply Retweet Like
PRECIS-2 retweeted
Shaun Treweek May 23
Wynne Norton: extending to multi-level interventions targeting healthcare providers. Some modified domains
Reply Retweet Like
PRECIS-2 May 23
Looking forward to seeing you all at the last, but not least, highlight of the conference 😊
Reply Retweet Like
PRECIS-2 retweeted
HSRU May 23
Our , and are pat of the workshop in last session of : 10.45 in Park room: What do we need to think about to make sure our trial is relevant to its intended users?
Reply Retweet Like
PRECIS-2 retweeted
Ella Flemyng May 22
Reply Retweet Like
PRECIS-2 retweeted
Stuart Nicholls May 22
. pragmatism on is not an end in itself. The PRECIS wheel should be shaped by the decision and the decision-makers requirement
Reply Retweet Like
PRECIS-2 retweeted
BMC Medical Evidence May 22
Merrick Zwarenstein at highlights that some of the challenges of pragmatic trials & using could have been overcome with detailed intervention development! These types of article are crucial & can be published in :
Reply Retweet Like
PRECIS-2 retweeted
BMC Medical Evidence May 22
PICO helps with the research question & helps with design, but how can you link this with ethics? at
Reply Retweet Like
PRECIS-2 retweeted
Stuart Nicholls May 22
. using retrospectively does pose issues in terms of availability of information
Reply Retweet Like
PRECIS-2 retweeted
Shaun Treweek May 22
Replying to @SG_Nicholls
I reckon a good starting point for a pragmatic approach to trial design is to think about who will use the trial results and then match your design decisions to their needs (preferably by involving them in design)
Reply Retweet Like
PRECIS-2 retweeted
Kirsty Loudon May 22
Informing real-world practice with real-world evidence: the value of PRECIS-2
Reply Retweet Like
PRECIS-2 retweeted
Shaun Treweek May 21
..and there's a workshop on PRECIS-2 at 10.45 on Wednesday 23rd.
Reply Retweet Like
PRECIS-2 retweeted
Kirsty Loudon May 21
So excited to participate with the king and queen of in invited Tuesday’s session 24 in Pavillion Ballroom East: “When pragmatism & reality collide” funded trials
Reply Retweet Like
PRECIS-2 retweeted
Journal of Clinical Epidemiology May 20
Differences between protocols for randomized controlled trials and systematic reviews
Reply Retweet Like